← All trials
NCT06543043
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 19, 2024
- Primary completion
- Sep 18, 2024
- Completion date
- Oct 4, 2024
- First posted
- Aug 7, 2024
- Last posted
- Aug 28, 2024
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BeOne MedicinesLead sponsor
- QuotientCollaborator
- BeOne MedicinesOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.